BIO-key International, Inc.

NasdaqCM:BKYI Stock Report

Market Cap: US$5.6m

BIO-key International Management

Management criteria checks 3/4

BIO-key International's CEO is Mike DePasquale, appointed in Jan 2003, has a tenure of 23.33 years. total yearly compensation is $309.49K, comprised of 92.1% salary and 7.9% bonuses, including company stock and options. directly owns 0.97% of the company’s shares, worth $54.27K. The average tenure of the management team and the board of directors is 9.3 years and 9.1 years respectively.

Key information

Mike DePasquale

Chief executive officer

US$309.5k

Total compensation

CEO salary percentage92.09%
CEO tenure23.3yrs
CEO ownership1.0%
Management average tenure9.3yrs
Board average tenure9.1yrs

Recent management updates

Analysis Article • Aug 01

We Think The Compensation For BIO-key International, Inc.'s (NASDAQ:BKYI) CEO Looks About Right

Key Insights BIO-key International's Annual General Meeting to take place on 8th of August CEO Mike DePasquale's total...

Recent updates

Analysis Article • Aug 01

We Think The Compensation For BIO-key International, Inc.'s (NASDAQ:BKYI) CEO Looks About Right

Key Insights BIO-key International's Annual General Meeting to take place on 8th of August CEO Mike DePasquale's total...
Analysis Article • Jan 01

BIO-key International (NASDAQ:BKYI) Is Carrying A Fair Bit Of Debt

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Seeking Alpha • Aug 12

BIO-key GAAP EPS of -$0.21, revenue of $1.9M

BIO-key press release (NASDAQ:BKYI): Q2 GAAP EPS of -$0.21. Revenue of $1.9M (+91.9% Y/Y). Outlook “BIO-key has built a strong base of products and services and a growing global footprint of partnerships and direct sales resources to address the substantial cybersecurity and IAM needs around the world. Given our progress to date and the growing scope of opportunities we are identifying, we remain confident in achieving our full-year 2022 revenue guidance of $10-13M, representing growth of over 100% above 2021. We believe BIO-key is positioned to achieve break-even operations within this range, subject to our mix of hardware and higher-margin software revenue. “Our guidance anticipates continued growth in recurring software license revenue to roughly 70% of the lower end of our revenue range, supported by hardware and services revenue contributions that are generally tied to specific projects. Our outlook is supported by our strong capital position, talented management and product development teams, and our expanding global sales, marketing and channel partner footprint.”
Analysis Article • Jun 12

Here's Why Shareholders May Want To Be Cautious With Increasing BIO-key International, Inc.'s (NASDAQ:BKYI) CEO Pay Packet

In the past three years, the share price of BIO-key International, Inc. ( NASDAQ:BKYI ) has struggled to grow and now...

CEO Compensation Analysis

How has Mike DePasquale's remuneration changed compared to BIO-key International's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2025n/an/a

-US$5m

Sep 30 2025n/an/a

-US$4m

Jun 30 2025n/an/a

-US$4m

Mar 31 2025n/an/a

-US$5m

Dec 31 2024US$309kUS$285k

-US$4m

Sep 30 2024n/an/a

-US$5m

Jun 30 2024n/an/a

-US$6m

Mar 31 2024n/an/a

-US$7m

Dec 31 2023US$292kUS$271k

-US$9m

Sep 30 2023n/an/a

-US$13m

Jun 30 2023n/an/a

-US$14m

Mar 31 2023n/an/a

-US$13m

Dec 31 2022US$372kUS$296k

-US$12m

Sep 30 2022n/an/a

-US$7m

Jun 30 2022n/an/a

-US$6m

Mar 31 2022n/an/a

-US$5m

Dec 31 2021US$277kUS$275k

-US$5m

Sep 30 2021n/an/a

-US$4m

Jun 30 2021n/an/a

-US$7m

Mar 31 2021n/an/a

-US$7m

Dec 31 2020US$349kUS$275k

-US$10m

Sep 30 2020n/an/a

-US$18m

Jun 30 2020n/an/a

-US$16m

Mar 31 2020n/an/a

-US$16m

Dec 31 2019US$311kUS$275k

-US$15m

Compensation vs Market: Mike's total compensation ($USD309.49K) is below average for companies of similar size in the US market ($USD619.80K).

Compensation vs Earnings: Mike's compensation has increased whilst the company is unprofitable.

CEO

Mike DePasquale (70 yo)

23.3yrs
Tenure
US$309,491
Compensation

Mr. Michael W. DePasquale, also known as Mike, has been the Chief Executive Officer of BIO-key International, Inc. since January 3, 2003. He has been the Chairman and Director of BIO-key International Inc....

Leadership Team

NamePositionTenureCompensationOwnership
Michael DePasquale
Chairman & CEO23.3yrsUS$309.49k0.97%
$ 54.3k
Kwok Fong Wong
MD of Hong Kong & Vice-Chairman of the Board10.4yrsno data0.32%
$ 18.2k
Cecilia Welch
Chief Financial Officer16.4yrsUS$222.00k0.55%
$ 30.6k
James Sullivan
Senior VP of Strategy & Compliance and Chief Legal Officer6.3yrsUS$325.18k0.90%
$ 50.2k
Mira LaCous
Chief Technology Officer12.2yrsUS$240.43k0.35%
$ 19.7k
Akintunde Jeje
Managing Director of Africa6.3yrsno datano data
Alex Rocha
Managing Director of EMEA4yrsno datano data
Mark Cochran
President of PortalGuardno datano datano data
9.3yrs
Average Tenure
63yo
Average Age

Experienced Management: BKYI's management team is seasoned and experienced (9.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Michael DePasquale
Chairman & CEO23.3yrsUS$309.49k0.97%
$ 54.3k
Kwok Fong Wong
MD of Hong Kong & Vice-Chairman of the Board10.4yrsno data0.32%
$ 18.2k
Cameron Williams
Independent Director2.9yrsUS$13.00k0.20%
$ 11.3k
Robert Michel
Independent Director9.1yrsUS$13.00k0.22%
$ 12.2k
Emmanuel Alia
Independent Director6.1yrsUS$12.00k0.20%
$ 11.0k
9.1yrs
Average Tenure
68yo
Average Age

Experienced Board: BKYI's board of directors are considered experienced (9.1 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/06 06:19
End of Day Share Price 2026/05/06 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BIO-key International, Inc. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jack Vander AardeMaxim Group